Controlled Radical Polymerization as an Enabling Approach for the Next Generation of Protein–Polymer Conjugates

Abstract

Protein-polymer conjugates are unique constructs that combine the chemical properties of a synthetic polymer chain with the biological properties of a biomacromolecule. This often leads to improved stabilities, solubilities, and in vivo half-lives of the resulting conjugates, and expands the range of applications for the proteins. However, early chemical methods for protein-polymer conjugation often required multiple polymer modifications, which were tedious and low yielding. To solve these issues, work in our laboratory has focused on the development of controlled radical polymerization (CRP) techniques to improve synthesis of protein-polymer conjugates. Initial efforts focused on the one-step syntheses of protein-reactive polymers through the use of functionalized initiators and chain transfer agents. A variety of functional groups such as maleimide and pyridyl disulfide could be installed with high end-group retention, which could then react with protein functional groups through mild and biocompatible chemistries. While this grafting to method represented a significant advance in conjugation technique, purification and steric hindrance between large biomacromolecules and polymer chains often led to low conjugation yields. Therefore, a grafting from approach was developed, wherein a polymer chain is grown from an initiating site on a functionalized protein. These conjugates have demonstrated improved homogeneity, characterization, and easier purification, while maintaining protein activity. Much of this early work utilizing CRP techniques focused on polymers made up of biocompatible but nonfunctional monomer units, often containing oligoethylene glycol meth(acrylate) or N-isopropylacrylamide. These branched polymers have significant advantages compared to the historically used linear poly(ethylene glycols) including decreased viscosities and thermally responsive behavior, respectively. Recently, we were motivated to use CRP techniques to develop polymers with rationally designed and functional biological properties for conjugate preparation. Specifically, two families of saccharide-inspired polymers were developed for stabilization and activation of therapeutic biomolecules. A series of polymers with trehalose side-chains and vinyl backbones were prepared and used to stabilize proteins against heat and lyophilization stress as both conjugates and additives. These materials, which combine properties of osmolytes with nonionic surfactants, have significant potential for in vivo therapeutic use. Additionally, polymers that mimic the structure of the naturally occurring polysaccharide heparin were prepared. These polymers contained negatively charged sulfonate groups and imparted stabilization to a heparin-binding growth factor after conjugation. A screen of other sulfonated polymers led to the development of a polymer with improved heparin mimesis, enhancing both stability and activity of the protein to which it was attached. Chemical improvements over the past decade have enabled the preparation of a diverse set...

Endo and Exo Diels–Alder Adducts: Temperature-Tunable Building Blocks for Selective Chemical Functionalization

“…Coupled with facile thiol-Michael addition, this strategy has significantly impacted the preparation of polymer-protein bioconjugates. 7 Maynard and co-workers expanded this work, demonstrating successful incorporation of exo furan-protected maleimides in reversible addition-fragmentation chain-transfer (RAFT) polymerization processes. 8 Dove and Sanyal also demonstrated successful utility in ring-opening polymerization (ROP) systems.…”

A Review of the Structure, Preparation, and Application of NLCs, PNPs, and PLNs

“…Zhang et al [65] and Sheng et al [66] prepared PNPs by the double-emulsion evaporation method. PLGA and PLA were used as polymers, and the sizes of the nanoparticles were 188 and 100–200 nm, respectively.…”

Responsive hybrid (poly)peptide–polymer conjugates

“…44 A range of PEG-alternatives such as poly(N-vinylpyrrolidone), 45 poly(glycerol), 46 poly(zwitterions), 47 poly(carbonates), 48 poly(oxazolines), 49 and poly(sacharrides), 50 have shown promise, and have been reviewed elsewhere. 51,52 In addition, polyphosphoesters (PPE) represent an important alternative to PEG because of their biocompatibility, biodegradability, similar architecture to biomolecules, and ability to be functionalized. 53 Recently, Wooley and co-workers developed a PPE-based nanocarrier which showed great promise in the treatment of lung metastasis of osteosarcoma.…”